top of page


What is needed for a evidence-based vaccination strategy?
Next week, COVID-19 vaccinations are set to begin in the UK after the BioNTech vaccine was approved there. EU approval is also not far off. There is great euphoria, and at the same time, it is clear: not everyone can be vaccinated at once. Very likely, not everyone wants to be vaccinated either. Acceptance and Voluntariness Require Credibility and Trust On November 9, a joint working group consisting of members from the Standing Committee on Vaccination, the German Ethics Cou


How many people does the COVID-19 vaccination protect?
Our Unstatistic of the Month for November addressed the question of how to correctly interpret statements about vaccine effectiveness. That contribution continues to make big waves to this day. Immediately after its publication, BR Faktenfuchs very differentiatedly addressed the topic of absolute and relative risk reduction, clarifying why the statement that the active ingredient protects 95% of vaccinated individuals from getting sick or even infected is not correct. However


Why the positive rate says as much (or as little) as the incidence rate
‘Coronavirus case numbers are meaningless. Unless you know something about testing. And even then, it gets complicated.’ So wrote Nate Silver, statistician and founder of FiveThirtyEight, almost exactly a year ago. But do we know enough about testing? Coronavirus Case Counts Are Meaningless* *Unless you know something about testing. And even then, it gets complicated. In October, we explained in the Unstatistic of the Month why the 7-day incidence, which shows the developmen
bottom of page
